EXOZYMES INC. - EXOZ
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$812K
QoQ value delta ($000)
+$132K
(+19.41%)
Implied price effect (QoQ)
-20.82%
Shares
Total shares
94,411
QoQ shares delta
+31,810
(+50.81%)
Total shares held by funds (by quarter)
Market chart (EXOZ)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 7 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 343 | 31,516 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 166 | 22,190 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 164 | 21,891 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 70 | 9,426 | 0.0% |
| BlackRock, Inc. | 51 | 6,797 | 0.0% |
| MORGAN STANLEY | 9 | 1,250 | 0.0% |
| Tower Research Capital LLC (TRC) | 9 | 1,317 | 0.0% |
| UBS Group AG | 0 | 24 | 0.0% |